POSA131 Costs of Relapsed/Refractory Acute Myeloid Leukemia (AML) in Colombia

Abstract

Authors

P Lasalvia Y Gil Rojas K Arciniegas Moreno LTM Saturnino

Full Text Cite This Article
Back to ISPOR Europe 2021 Abstracts: Emerging Frontiers and Opportunities
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×